The Drug Dose Gender Gap
Does equal always mean fair?
Maryam Mahdi | | Quick Read
Across industries, women and their allies have fought to close the gender gap. For pharma, the problem is not only a professional one – it affects the health of female patients worldwide. And now, using data from over 2,000 journal articles, researchers from the University of California, Berkeley and the University of Chicago, have found that 86 FDA-approved drugs are affected by a drug dosing gender gap (1).
“The common practice of prescribing equal drug doses to women and men neglects sex differences in pharmacokinetics, dimorphisms in body weight, and risks overmedication of women,” says Irving Zucker, the study’s lead author. “We discovered that 76 of the 86 drugs we investigated had negative effects in female patients.”
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine